Business Context and Reporting Period
This Form 8-K Current Report was filed by Abbott Laboratories on April 26, 2002. The report addresses a corporate governance event regarding the appointment of a new independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific event rather than a financial statement.
Material Changes
- Change in Certifying Accountant: On April 26, 2002, the Board of Directors, upon the recommendation of the Audit Committee, engaged Deloitte & Touche LLP as the company's independent auditors.
- Consultation History: During the two most recent fiscal years and the subsequent interim period, neither Abbott nor its representatives consulted with Deloitte regarding matters or reportable events listed in Items 304(a)(2)(i) and (ii) of Regulation S-K.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the change in auditors.
Investor Verification Checklist
- Verify the effective date of the engagement with Deloitte & Touche LLP.
- Confirm the identity of the previous independent auditor to understand the full scope of the transition.
- Review subsequent filings (e.g., 10-K or 10-Q) to assess the impact of the auditor change on financial reporting.